5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation

5-Fluorouracil (5-FU) remains the first-line treatment for colorectal cancer (CRC). Although 5-FU initially de-bulks the tumor mass, recurrence after chemotherapy is the barrier to effective clinical outcomes for CRC patients. Here, we demonstrate that p53 promotes WNT3 transcription, leading to act...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yong-Hee, Ro, Eun Ji, Yoon, Jeong-Su, Mizutani, Tomohiro, Kang, Dong-Woo, Park, Jong-Chan, Il Kim, Tae, Clevers, Hans, Choi, Kang-Yell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578039/
https://www.ncbi.nlm.nih.gov/pubmed/33087710
http://dx.doi.org/10.1038/s41467-020-19173-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578039/
https://www.ncbi.nlm.nih.gov/pubmed/33087710
http://dx.doi.org/10.1038/s41467-020-19173-2

Ejemplares similares